Chohan, K., Feng, L., Cochran, H., Rosenberg, M., Isenalumhe, L., Yilmaz, E., … Ahmed, S. (2025). Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma. In Blood (Vol. 146, pp. 1852–1852). American Society of Hematology. https://doi.org/10.1182/blood-2025-1852

Chohan, Karan, Lei Feng, Hunter Cochran, Maya Rosenberg, Leidy Isenalumhe, Elif Yilmaz, Seo-Hyun Kim, et al. “Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma.” In Blood, 146:1852–1852. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-1852.

Chohan K, Feng L, Cochran H, Rosenberg M, Isenalumhe L, Yilmaz E, et al. Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma. In: Blood. American Society of Hematology; 2025. p. 1852–1852.

Chohan, Karan, et al. “Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 1852–1852. Crossref, doi:10.1182/blood-2025-1852.

Chohan K, Feng L, Cochran H, Rosenberg M, Isenalumhe L, Yilmaz E, Kim S-H, Tiger YK, Torka P, Flanagan H, Castellino S, Bender J, Kannaiyan R, Kahla J, DePriest BP, Narvel H, Catueno S, Tobon K, Fadul J, Faulkenberry P, Ayers A, Nathan S, Mubeen S, Luttwak E, Flerlage J, Norris R, Kaur S, Tran O, Wannaphut C, Hawk A, Garcia M, Cuglievan B, Riedell P, Mahadeo K, Hamadani M, Diefenbach C, Bartlett N, Ahmed S. Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma. Blood. American Society of Hematology; 2025. p. 1852–1852.